RxAnte Recognized by the Financial Times as One of the Americas’ Fastest-Growing Companies

RxAnte is proud to announce our inclusion in the Financial Times’ Americas’ Fastest-Growing Companies 2025 list.

This recognition reflects RxAnte’s strong growth and ongoing leadership in pharmacy care management and healthcare analytics. As healthcare organizations continue to seek better ways to improve medication use, lower costs, and enhance outcomes, RxAnte has expanded by delivering targeted, data-driven solutions that meet those needs.

The Financial Times and Statista ranking is based on independently verified revenue performance over a three-year period. Eligible companies were required to meet specific revenue thresholds, remain independent, and demonstrate primarily organic growth.

We are grateful to our employees, clients, and partners for helping make this recognition possible, and we look forward to continuing to drive meaningful impact across healthcare. To read the full the article, click here.